Andrew Hirsch

Company: C4 Therapeutics

Job title: President & Chief Executive Officer

Seminars:

CEO Think Tank: A Strategic Look at Targeted Protein Degradation & Induced Proximity Field 9:30 am

Moderator: Neil Torbett, Chief Executive Officer, Phoremost Assessing what we are learning from clinical candidates Considering pipeline prioritization for mid to large biotechs progressing multiple programs Advice to fledging biotechs on advancing through discovery and enabling clinical successRead more

day: Day One AM